Back to Trades
Other4
Organon & Co.
OGN
Total Value
$35.0K
Company Information
- Company Name
- Organon & Co.
- Ticker Symbol
- OGN
- CIK
- 0001821825
Insider Information
- Name
- Falcione Aaron
- Role
- Chief Human Resources Officer
- Location
- JERSEY CITY, NJ
Officer
Filing Details
- Filing Date
- Apr 2, 2026
- Transaction Date
- Mar 31, 2026
- Accession Number
- 0001628280-26-023150
- Form Type
- 4
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Mar 31, 2026 | Common Stock | 6,732 | — | Exercise | — |
| Mar 31, 2026 | Common Stock | 2,306 | $5.70 | Tax Withholding | $13.1K |
| Mar 31, 2026 | Common Stock | 11,193 | — | Exercise | — |
| Mar 31, 2026 | Common Stock | 3,834 | $5.70 | Tax Withholding | $21.9K |
Derivative Transactions
| Date | Security | Shares | Exercise Price | Type | Value |
|---|---|---|---|---|---|
| Mar 31, 2026 | Derivative | 166,944 | — | Grant/Award | — |
| Mar 31, 2026 | Derivative | 6,732 | — | Exercise | — |
| Mar 31, 2026 | Derivative | 11,193 | — | Exercise | — |
Footnotes
- (F1)The price is the closing market price of Organon & Co. ("Organon") common stock on Monday, March 30, 2026, as required by the plan under which the Restricted Stock Units ("RSU") were awarded.
- (F2)On March 31, 2026, the Reporting Person was granted 166,944 RSUs, with each RSU representing a contingent right to receive one share of Organon common stock. These RSUs will vest and become exercisable in three equal installments on March 31, 2027, March 31, 2028, and March 31, 2029.
- (F3)Each RSU represents a contingent right to receive one share of Organon common stock.
- (F4)On March 31, 2023, the Reporting Person was granted 20,195 RSUs. Two-thirds of such RSUs previously vested, and the remaining one-third vested on March 31, 2026.
- (F5)On March 31, 2025, the Reporting Person was granted 33,579 RSUs. One-third of such RSUs vested on March 31, 2026, with the remaining to vest on March 31, 2027 and March 31, 2028.